注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Oramed Pharmaceuticals IncOramed Pharmaceuticals Inc.是一家製藥公司。該公司從事藥物溶液的研發業務,包括治療糖尿病個體的口服胰島素膠囊以及遞送其他多肽的口服可攝取膠囊或丸劑。該公司的旗艦產品ORMD-0801是一種口服可攝取胰島素膠囊。截至2016年8月31日,該公司已完成治療2型糖尿病的ORMD-0801 的第二b期臨床試驗。胰高血糖素樣肽-1(GLP-1)是一種腸促胰島素激素,即一種刺激胰腺分泌胰島素的胃腸類激素。該公司的其他產品是口服可攝取GLP-1膠囊ORMD-0901。截至2016年8月31日,ORMD-0901處於治療2型糖尿病第一期臨床試驗。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Xiaoming Gao | 58 | 2019 | Independent Director |
Arie Mayer | 66 | 2019 | Independent Director |
Jay S. Skyler | 75 | 2020 | Member of Scientific Advisory Board |
G. Alexander Fleming | - | 2020 | Member of Scientific Advisory Board |
Julio Rosenstock | - | 2020 | Member of Scientific Advisory Board |
Nadav Kidron | 48 | 2006 | President, CEO & Executive Chairman |
Avram Hershko | 86 | 2008 | Member of Scientific Advisory Board |
Leonard Sank | 58 | 2007 | Independent Director |
Roy Eldor | - | 2016 | Member of the Scientific Advisory Board |
Eleuterio Ferrannini | - | 2007 | Member of Scientific Advisory Board |
Harold Jacob | 69 | 2008 | Member of Scientific Advisory Board |
Miriam Kidron | 83 | 2006 | Chief Scientific Officer & Director |
Anne L. Peters | - | 2022 | Member of Scientific Advisory Board |
Benjamin Shapiro | 40 | 2023 | Independent Director |
Daniel Aghion | 42 | 2024 | Independent Director |
Yehuda Reznick | 76 | 2024 | Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核